Speaker

Jeffrey Jones

Chief Medical Officer, Cullinan Therapeutics, Inc.

Jeffrey Jones, Chief Medical Officer at Cullinan Therapeutics, Inc., is speaking at 2nd T-Cell Engager for Autoimmune Disease Summit (Boston, United States of America, 27–29 Oct 2026) in the session “Demonstrating Deep B-Cell Reset with CLN-978 by Translating Early Clinical Insights Moving Beyond Early Development”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

2nd T-Cell Engager for Autoimmune Disease Summit
27–29 Oct 2026Boston, United States of America
- SpeakerDemonstrating Deep B-Cell Reset with CLN-978 by Translating Early Clinical Insights Moving Beyond Early Development
- PanelPanel Discussion: Translating First-Wave Autoimmune T-Cell Engager Clinical Data into Safer, More Effective Next-Generation Therapies

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Jeffrey Jones, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].